Ferric maltol
- Generic Name
- Ferric maltol
- Brand Names
- Accrufer, Feraccru
- Drug Type
- Small Molecule
- Chemical Formula
- C18H15FeO9
- CAS Number
- 33725-54-1
- Unique Ingredient Identifier
- MA10QYF1Z0
- Background
Ferric maltol is an iron(III) atom complexed with 3 maltol molecules to increase the bioavailability compared to iron(II), without depositing it in the duodenum as insoluble ferric hydroxide and phosphate. Ferric maltol has been described in literature since at least the late 1980s as a potential treatment for iron deficiency.
Ferric maltol was granted FDA Approval on 25 July 2019.
- Indication
Ferric maltol is indicated to treat iron deficiency in adults.
- Associated Conditions
- Iron Deficiency (ID)
- Associated Therapies
- -
Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years
- Conditions
- AnemiaIron-deficiency
- Interventions
- First Posted Date
- 2021-11-19
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Shield Therapeutics
- Target Recruit Count
- 65
- Registration Number
- NCT05126901
- Locations
- 🇺🇸
The Center for Clinical Trials, Saraland, Alabama, United States
🇺🇸Homestead Research Institute, Homestead, Florida, United States
🇺🇸Kissimmee Clinical Research Corp, Kissimmee, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.